Literature DB >> 16887484

People's perceptions of cancer survivability: implications for oncologists.

Robert J Donovan1, Owen B J Carter, Michael J Byrne.   

Abstract

Individuals typically overestimate survival for lung cancer and underestimate it for melanoma. However, reporting of results generally masks the extent of disagreement between people on survival rates. Most methods used to question individuals are of little use and are not comparable across studies. The topic of people's perceptions of survival for various cancers is under-researched. A clearer definition is needed of survivability, as is a standard way to measure it and then present the information. We have undertaken a review of studies reporting public perceptions of cancer survival rates and compared the results, where possible, with actual survival rates. We also investigate some potential implications of people's underestimation or overestimation of survival for screening and prevention behaviours and delineate implications for oncologists.

Entities:  

Mesh:

Year:  2006        PMID: 16887484     DOI: 10.1016/S1470-2045(06)70794-X

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  9 in total

1.  Cancer: it's time to change the sign.

Authors:  James Downar
Journal:  CMAJ       Date:  2010-09-13       Impact factor: 8.262

2.  Conditional survival among cancer patients in the United States.

Authors:  Ray M Merrill; Bradley D Hunter
Journal:  Oncologist       Date:  2010-07-20

3.  Cancer versus heart failure patient self-declared potential interest in clinical trials.

Authors:  Maurie Markman; Larie Smoyer; J Timothy Marron; Robert Montgomery
Journal:  Curr Oncol Rep       Date:  2007-01       Impact factor: 5.075

4.  Actual prognosis during follow-up of survivors of B-cell non-Hodgkin lymphoma in the Netherlands.

Authors:  Saskia A M van de Schans; Liza N van Steenbergen; Jan Willem W Coebergh; Maryska L G Janssen-Heijnen; Dick Johan van Spronsen
Journal:  Haematologica       Date:  2013-09-13       Impact factor: 9.941

5.  Bending the cost curve in cancer care.

Authors:  Thomas J Smith; Bruce E Hillner
Journal:  N Engl J Med       Date:  2011-05-26       Impact factor: 91.245

6.  Public perception of cancer care in Poland and Austria.

Authors:  Mariusz Jȩdrzejewski; Christiane Thallinger; Magda Mrozik; Gabriela Kornek; Christoph Zielinski; Jacek Jassem
Journal:  Oncologist       Date:  2014-12-17

7.  Is Korean society prepared for the financial burden of novel anticancer drugs? A survey of willingness to pay among National Health Insurance beneficiaries.

Authors:  Kyu-Tae Han; Ye Lee Yu; Woorim Kim; Sokbom Kang
Journal:  Support Care Cancer       Date:  2021-05-08       Impact factor: 3.603

8.  Do the British public recognise differences in survival between three common cancers?

Authors:  K L Whitaker; A E Simon; R J Beeken; J Wardle
Journal:  Br J Cancer       Date:  2012-05-03       Impact factor: 7.640

9.  Incidence trend and conditional survival estimates of gastroenteropancreatic neuroendocrine tumors: A large population-based study.

Authors:  Qing Zhong; Qi-Yue Chen; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Jun Lu; Long-Long Cao; Mi Lin; Ru-Hong Tu; Ze-Ning Huang; Ju-Li Lin; Ping Li; Chao-Hui Zheng; Chang-Ming Huang
Journal:  Cancer Med       Date:  2018-06-05       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.